CD5 positive B-ALL, a uniquely aggressive subcategory of B-ALL? A case report and brief review of the literature

Pediatr Blood Cancer. 2019 Jan;66(1):e27484. doi: 10.1002/pbc.27484. Epub 2018 Sep 30.

Abstract

CD5 antigen expression in B-cell acute lymphoblastic leukemia (B-ALL) is exceptionally rare. There are six detailed case reports in the literature, with only 16 cases described. Case series analyzing the frequency of aberrant B-ALL immunophenotypes suggest that this variant may occur in as little as 2-4.5% of all B-ALL cases, with one series having no CD5+ positive cases. Herein we report a case of CD5+ B-ALL in a 15-year-old female, and review the previously reported cases. As limited information is available, more data from prospective clinical trials are required to determine whether CD5 positivity portends a poorer prognosis.

Keywords: B-cell ALL; CD5+; acute lymphoblastic leukemia; immunophenotypic aberrancies in ALL; variant B-ALL.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • CD5 Antigens / metabolism*
  • Fatal Outcome
  • Female
  • Humans
  • Neoplasm Recurrence, Local / metabolism
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Recurrence, Local / therapy
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / metabolism
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy

Substances

  • CD5 Antigens